MoonLake Immunotherapeutics (MLTX) Short-term Investments (2022 - 2026)
MoonLake Immunotherapeutics (MLTX) posted quarterly Short-term Investments of $59.4 million for Q1 2026, down 71.5% year-over-year from $208.6 million in Q1 2025, and little changed quarter-over-quarter from $59.5 million in Q4 2025.
MoonLake Immunotherapeutics (MLTX) Short-term Investments (2022 - 2026) Analysis & Trends
MoonLake Immunotherapeutics' Short-term Investments history runs 5 years deep, the most recent figure standing at $59.4 million for Q1 2026.
- In Q1 2026, Short-term Investments fell 71.5% year-over-year to $59.4 million; the TTM figure through Mar 2026 stood at $59.4 million (down 71.5% YoY), while the FY2025 annual figure was $59.5 million, down 77.78% from the prior year.
- Short-term Investments for Q1 2026 stood at $59.4 million, roughly flat from $59.5 million in the prior quarter.
- The five-year high for Short-term Investments was $267.6 million in Q4 2024, with the low at $12.9 million in Q1 2023.
- The 5-year median for Short-term Investments is $88.6 million (2024), against an average of $103.6 million.
- The sharpest annual moves came in 2023 and 2024: Short-term Investments sank 87.23% in 2023, then jumped 586.93% in 2024.
- MoonLake Immunotherapeutics' Short-term Investments stood at $32.6 million in 2022, then jumped by 83.5% to $59.8 million in 2023, then surged by 347.2% to $267.6 million in 2024, then sank by 77.78% to $59.5 million in 2025, then retreated by 0.03% to $59.4 million in 2026.
- Business Quant data shows MLTX's Short-term Investments at $59.4 million in Q1 2026, $59.5 million in Q4 2025, and $29.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | MoonLake Immunotherapeutics | 1.40 Bn | 864.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 59.13 Mn |
| Mar 31, 2026 | 59.43 Mn |
| Dec 31, 2025 | 59.45 Mn |
| Sep 30, 2025 | 29.74 Mn |
| Jun 30, 2025 | 118.40 Mn |
| Mar 31, 2025 | 208.56 Mn |
| Dec 31, 2024 | 267.60 Mn |
| Sep 30, 2024 | 118.27 Mn |
| Jun 30, 2024 | 177.01 Mn |
| Mar 31, 2024 | 88.61 Mn |
| Dec 31, 2023 | 59.84 Mn |
| Sep 30, 2023 | 177.81 Mn |
| Mar 31, 2023 | 12.90 Mn |
| Dec 31, 2022 | 32.61 Mn |
| Sep 30, 2022 | 42.25 Mn |
| Mar 31, 2022 | 101.00 Mn |